MTRY
Monterey Bio Acquisition Corp
A special purpose acquisition company, or "blank check" company, Monterey Bio was created in 2020 to raise money and find a biotech business to buy and merge with. It launched with a public stock offering in 2021, then renamed itself Monterey Innovation Acquisition Corp. in 2023 to broaden its hunt to disruptive tech. Unable to complete a deal by its deadline, the company chose to wind down and return its cash to shareholders that same year, ending its run without ever acquiring a target.
SPACUnderlying: MTRYCUSIP: 61240F108FinancialsUS1 holder
Common stock — Liquidated in November 2023 after failing to complete business combination
Recent Activity
2022Q4
1 sell
-150.0K shares
-150.0K shares
Loading more activity...